Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer's Disease Randomized Controlled Trial is a research paper published in The Journal of Prevention of Alzheimer s Disease (2024). On theSindex it has a DataRank of 0.408. It has been cited 7 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0.0961
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
NIA NIH HHS
Grant: P30 AG066518
NIA NIH HHS
Grant: R01 AG063689
National Institutes of Health
Grant: 5R01AG063689-02
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study
National Institutes of Health
Grant: 3U19AG010483-26S4
Alzheimer's Disease Cooperative Study
National Institutes of Health
Grant: 3U24AG057437-02S1
Alzheimers Clinical Trials Consortium (ACTC)
FWCI
3.49
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals